Universal-Beteiligungs- und Servicegesellschaft’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6M Sell
116,373
-15,562
-12% -$3.05M 0.04% 364
2026
Q1
$25.8M Buy
131,935
+12,066
+10% +$2.34M 0.04% 333
2025
Q4
$20.9M Sell
119,869
-67,214
-36% -$12.2M 0.03% 382
2025
Q3
$35.7M Sell
187,083
-11,374
-6% -$2.02M 0.06% 265
2025
Q2
$35.6M Sell
198,457
-21,269
-10% -$3.69M 0.06% 265
2025
Q1
$37.2M Sell
219,726
-3,644
-2% -$599K 0.07% 243
2024
Q4
$33.7M Buy
+223,370
New +$34.7M 0.07% 258

Other funds holding DGX

Universal-Beteiligungs- und Servicegesellschaft's DGX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Quest Diagnostics (DGX) stake by 12% in Q2 2026, selling an estimated $3.05M and leaving 116,373 shares worth $24.6M. The position accounts for 0.04% of the portfolio, ranked #364.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $37.2M in Q1 2025. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 116,373 shares of Quest Diagnostics worth $24.6M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 15,562 Quest Diagnostics shares in Q2 2026, an estimated $3.05M.
  • Quest Diagnostics made up 0.04% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #364 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Quest Diagnostics position peaked at $37.2M in Q1 2025.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.